In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response-Reference-Cited by-同舟云学术

In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response

Published:2015-09-01 Issue:9 Volume:10 Page:e0135444
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Braun Floriane C. M.,van den Brandt Jens,Thomas Sören,Lange Sandra,Schrank Juliane,Gand Claudia,Przybylski Grzegorz K.,Schmoeckel Katrin,Bröker Barbara M.,Schmidt Christian A.,Grabarczyk Piotr

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Tumor-driven evolution of immunosuppressive networks during malignant progression;R Kim;Cancer Res,2006

2. Immunosuppressive strategies that are mediated by tumor cells;GA Rabinovich;Annu Rev Immunol,2007

3. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppression;XT Song;Nat Med,2008

4. A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme;BA Malynn;J Exp Med,2009

5. The role of ubiquitin in NF-kappaB regulatory pathways;B Skaug;Annu Rev Biochem,2009

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On the Impairment of Stress-Induced Changes in Triglyceride Levels via a Sub-Toxic Dose of Unmethylated Cytidine Phosphate Guanosine Oligodinucleotide (a Toll-Like Receptor 9 Ligand);Journal of Biosciences and Medicines;2024

2. Functional Nucleic Acid-Based Immunomodulation for T Cell-Mediated Cancer Therapy;ACS Nano;2023-12-20

3. Targeted RNA therapeutics for treatment of cancer and immunomodulation;RNA Therapeutics;2022

4. The dual roles of A20 in cancer;Cancer Letters;2021-07

5. A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma;Journal for ImmunoTherapy of Cancer;2020-12